HIF1A and cancer: Based on our in vitro data illustrating 2-ANPC’s potency in decreasing HIF-1α in cancer lines (as shown in Figure 3), we examined whether the antitumor activity of this amino-pyrrole derivative was due to its ability to decrease HIF-1α expression in vivo.